NASDAQ
Black Diamond Therapeutics, Inc. (BDTX) has a current ratio of 8.42x as of Monday, May 25, 2026. This represents a 15.20% increase compared to its 12-month average of 7.31x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.